Nippon India Pharma Fund

Equity Small CapVery High RiskGrowthInception 31-Dec-2012

Overview

Current NAV
564.7617
As on 30-Dec-2025
Fund Size
8,458.683 Cr
Managed by Sailesh Raj Bhan
Expense Ratio
0.92%
Latest reported
Exit Load Rules
3
Conditions apply

Scheme Snapshot

This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 31-Dec-2012. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.

Data shown is for informational purposes only and may be delayed.

Returns

Green = Positive, Red = Negative
PeriodAbsolute %CAGR %Category %Index %
1D-0.54
1W-1.33
1M-2.55
3M1.961.47
6M-1.780.20
1Y-1.74-2.14
3Y22.4222.4222.11
5Y16.0416.0414.61
10Y13.8913.89

Top Holdings

Portfolio Allocation (Top 8+)

Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
13.55
Lupin Ltd.
EQ
Healthcare
7.59
Divi's Laboratories Ltd.
EQ
Healthcare
6.90
Cipla Ltd.
EQ
Healthcare
6.33
Dr. Reddy's Laboratories Ltd.
EQ
Healthcare
5.83
Apollo Hospitals Enterprise Ltd.
EQ
Healthcare
5.63
Medplus Health Services Ltd.
EQ
Healthcare
3.47
Vijaya Diagnostic Centre Ltd.
EQ
Healthcare
3.41
Ajanta Pharma Ltd.
EQ
Healthcare
2.90
Glaxosmithkline Pharmaceuticals Ltd.
EQ
Healthcare
2.77
Gland Pharma Ltd.
EQ
Healthcare
2.75
Sai Life Sciences Ltd.
EQ
Healthcare
2.67

Analysis Highlights

PROS
Consistently higher annualised returns than category average for the past 1Y, 3Y, 5Y and 10Y
PROS
Lower expense ratio: 0.92%

Exit Load

  • Exit load of 1% if redeemed within 1 month.2020-05-21
  • For units more than 10% of the investments, an exit load of 1% if redeemed within 12 months.2020-03-17
  • Exit load of 1% if redeemed within 1 year2013-01-01
Ask AI